Informed Consent Form (ICF)
Study: CTL-2025-001 | Version 1.0 | 23-Jun-2025
Thank you for considering participation in this study.
KEY FACTS
• About 110 participants will take part in this research.
• The study will last approximately 12 months.
• You will be asked to attend 8 clinic visits.
PURPOSE
The purpose of this study is to evaluate Drug X.
PROCEDURES
You will be randomly assigned to receive Drug X or placebo.
RISKS & BENEFITS
...
CONTACT INFORMATION
...